Immunostimulant agent among the following is :
**Question:** Immunostimulant agent among the following is:
A. Interferon-alpha
B. Interferon-gamma
C. Interleukin-2
D. Glucocorticoids
**Correct Answer:** **C. Interleukin-2**
**Core Concept:** Immunostimulants are medications that enhance the immune system's ability to fight infections and tumors. They can be broadly classified into two categories: immunomodulators and immunostimulants. Immunomodulators are drugs that alter the immune system's function without directly stimulating immune cell activity, while immunostimulants are substances that directly stimulate immune cell function.
**Why the Correct Answer is Right:** Interleukin-2 (IL-2) is a cytokine, which is a type of protein that plays a crucial role in the immune response. IL-2 is produced by activated T-cells and natural killer cells and acts on various immune cells to stimulate their proliferation, differentiation, and cytotoxic activity.
**Why Each Wrong Option is Incorrect:**
A. Interferon-alpha (IFN-alpha) is a type of antiviral protein produced by immune cells in response to viral infections. Though IFN-alpha has immunomodulatory effects, it does not directly stimulate immune cell activity, making it a wrong choice for an immunostimulant.
B. Interferon-gamma (IFN-gamma) is a cytokine produced mainly by activated T-cells and natural killer cells. Although IFN-gamma is involved in immune response modulation, it does not directly stimulate immune cell activity, rendering it a wrong choice for an immunostimulant.
C. Glucocorticoids, such as dexamethasone, are a class of steroid hormones with potent anti-inflammatory and immunosuppressive effects. Although glucocorticoids can modulate immune response, they do not directly stimulate immune cell activity, making them an incorrect choice for an immunostimulant.
**Clinical Pearl:**
Interleukin-2 (IL-2) is a potent immunostimulant used in the treatment of certain cancers, particularly renal cell carcinoma and melanoma, as well as hairy cell leukemia and Kaposi's sarcoma. IL-2 therapy involves administering recombinant IL-2, which stimulates T-cell proliferation, cytotoxicity, and the activation of natural killer cells, thereby enhancing the immune system's ability to target and eliminate cancer cells.
**Why Each Wrong Option is Incorrect:**
A. Interferons (IFNs), including interferon-alpha (IFN-alpha) and interferon-gamma (IFN-gamma), are proteins produced by immune cells in response to viral infections. Although they have immunomodulatory effects, they do not directly stimulate immune cell activity, making them incorrect choices for an immunostimulant.
B. Glucocorticoids, like dexamethasone, have immunosuppressive effects due to their anti-inflammatory and anti-proliferative properties. They do not directly stimulate immune cell activity, rendering them an incorrect choice for an immunostimulant.
D. Glucagon, a hormone